RATIONALE: This is an update of an existing review. The main clinical intervention for mild to moderate hearing loss is the provision of hearing aids, which amplify speech in addition to environmental sounds. Hearing aids are routinely offered and fitted to those who seek help for hearing difficulties. Since the previous 2017 review, further randomised-controlled trials (RCTs) have been published....
✦ The floor
Discussion
Signed responses from readers of the wire.
Audiologists should monitor this updated Cochrane review's conclusions closely; if it confirms benefit, it strengthens the case for fitting hearing aids in mild-loss patients who are currently under-served.
An updated Cochrane systematic review on hearing aids for mild-to-moderate loss represents the highest level of evidence available and could directly influence clinical guidelines and third-party coverage decisions worldwide.
- 01Updated Cochrane systematic review (CD012023, 3rd edition) on hearing aids for mild-to-moderate adult hearing loss.
- 02Cochrane reviews represent the gold standard of evidence synthesis (systematic review of available trials).
- 03Findings could influence clinical guidelines on when to recommend hearing aids.
- 04Mild-to-moderate hearing loss is the most prevalent category globally, making this high-impact.
- 05Results carry implications for insurance coverage and public health policy on hearing aid access.
Hearing aids are effective as the primary intervention for mild to moderate hearing loss in adults.
studysupported- PMID
- 42644645
- DOI
- 10.1002/14651858.CD012023.pub3.
- Journal
- Cochrane Database of Systematic Reviews
- Publication type
- meta_analysis
- Evidence level
- 1a
- Population
- Adults with mild to moderate hearing loss
- Intervention
- Hearing aids
- Comparator
- No hearing aids / placebo / usual care
Primary outcomes
Effectiveness of hearing aids on hearing outcomes; Quality of life and functional hearing improvement; Adverse effects and patient-reported outcomes